HOME >> BIOLOGY >> NEWS
Unusual antibiotics show promise against deadly 'superbugs'

WASHINGTON, Aug. 29 An unusual type of antibiotic being developed by chemists at University of Notre Dame shows promise in defeating deadly "superbugs" highly drug-resistant staph bacteria that are an increasing source of hospital-based infections. The novel antibiotics, which could some day save lives, were described today at the 230th national meeting of the American Chemical Society, the worlds largest scientific society.

The new antibiotics are synthetic forms of cephalosporin, a broad-spectrum antibiotic closely related to penicillin. They appear to kill bacteria by masquerading as components of the bacterial cell wall in order to deactivate an enzyme that functions as a key bacterial defense mechanism, the researchers say. In preliminary lab tests, the new antibiotics the first to exhibit this mimicry mechanism were effective against vancomycin-resistant MRSA, a rare but extremely deadly staph strain for which treatment options are extremely limited, they say.

"We are the first to demonstrate this unique strategy, which could provide a new line of defense against the growing problem of antibiotic resistance," says study leader Shahriar Mobashery, Ph.D., a chemist at the university. "As scientists, were trying to stay one step ahead of the bacteria. The more strategies there are to fight resistance, the better."

Besides fighting staph bacteria, the compounds have the potential to work against a wide range of other types of infectious bacterial strains that appear in health-care and community settings, he says. At least one of the cephalosporin compounds identified has entered Phase I clinical trials (human studies), but results are not yet available. More studies are needed before it can be marketed, Mobashery and his associates say.

MRSA (methicillin-resistant Staphylococcus aureus) was first identified in the early 1960s and has become a difficult superbug to tame. While searching for strategies to defeat it, Mobasher
'"/>


29-Aug-2005


Page: 1 2 3

Related biology news :

1. Unusual three-drug combo inhibits growth of aggressive tumors
2. Unusual data shed new light on brain and inhibiting behavior
3. Unusual mechanism keeps repair protein accurate
4. Unusual RNAs linked to chronic leukemia, may help treat it
5. Unusual reproductive behavior of odd ants surprises scientists
6. Researchers watch antibiotics, bacteria meet at atomic level
7. UBC researchers find new superbug weapon for near-empty antibiotics arsenal
8. Will the plague pathogen become resistant to antibiotics?
9. Natural antibiotics yield secrets to atom-level imaging technique
10. Compounds in cranberry juice show promise as alternatives to antibiotics
11. Protein clue to tailor-made antibiotics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... January 16, 2019 , ... January has been a record-breaking month so far ... has the company already hosted several of its signature cooking classes and team-building events, ... Pharmaceuticals, later this month. , Since 2008, Lajollacooks4u’s team-building events have been a ...
(Date:1/14/2019)... ... January 14, 2019 , ... ... detect precancer and cancer cells in blood, will present new findings at the ... the fight against colorectal cancer. The results from this study show CellMax Life’s ...
(Date:1/10/2019)... ... , ... When Dr. James L. Sherley, M.D., Ph.D., founder and director of ... to the new book Perinatal Stem Cells: Research and Therapy, he knew immediately what ... secret of stem cell medicine. For more than a half-century, stem cell medicine ...
Breaking Biology News(10 mins):
(Date:2/12/2019)... (PRWEB) , ... February 12, 2019 , ... ... in dermatology, has finalized a deal to extend their use of Medrio, the ... trials, through 2023. The CRO has been a regular Medrio customer for over ...
(Date:2/2/2019)... ... January 31, 2019 , ... Signature Matrix and ... perinatal tissue by applied stem cell research expert and Amazon best-selling author, Neil ... a flowable umbilical cord tissue allograft that originates from the same tissue used ...
(Date:1/30/2019)... ... 29, 2019 , ... Mr. Schieving has served as the ... Director of Sales and Marketing, Mr. Schieving was instrumental in positioning Lifecycle as ... supports. During this time, Mr. Schieving was responsible for establishing internal and external ...
(Date:1/30/2019)... N.J. (PRWEB) , ... January 30, 2019 , ... ... together experts from pharma, academia and governmental agencies to discuss best practices for ... DC from February 4-6. , At this year’s conference, Visikol will be ...
Breaking Biology Technology:
Cached News: